Evidence map›Paper›PMID 35159288›Full record

SynthesisCells2022

Can We Use

Liming Xie, Qi Zhu, Jiahong Lu

Open access · goldAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Investigation of the Potential Neuroprotective Mechanisms ofInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Evolving of treatment options for cerebral infarction.World journal of clinical cases · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. New Value ofNutrients · 2024
    Article
  17. Review
  18. Future science OA · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Liming XieState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR 999078, China.
Qi ZhuState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR 999078, China.
Jiahong LuState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR 999078, China.ORCID 0000-0002-1147-125X
University of Macau · MO

Funding

Macau SAR FDCT-0110/2018/A3, FDCT-024-2017-AMJ, FDCT-0128/2019/A3University of Macau MYRG2019-00129-ICMS
6 · The paper itself

Abstract

(1) Background:

Indexed as

Alzheimer DiseaseGinkgo bilobaAnimalsCognitionGinkgo ExtractHumansMicePlant ExtractsRatsGinkgo biloba extractGinkgo ExtractPlant ExtractsAlzheimer’s diseaseclinical trialGinkgo biloba extractmeta-analysis

Identifiers

PMID35159288
PMCPMC8833923
OpenAlexW4212898692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.